AU2001295483A1 - Solid peptide preparations for inhalation, and the production thereof - Google Patents

Solid peptide preparations for inhalation, and the production thereof

Info

Publication number
AU2001295483A1
AU2001295483A1 AU2001295483A AU9548301A AU2001295483A1 AU 2001295483 A1 AU2001295483 A1 AU 2001295483A1 AU 2001295483 A AU2001295483 A AU 2001295483A AU 9548301 A AU9548301 A AU 9548301A AU 2001295483 A1 AU2001295483 A1 AU 2001295483A1
Authority
AU
Australia
Prior art keywords
inhalation
production
peptide preparations
solid peptide
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295483A
Inventor
Michael Damm
Rosario Lizio
Werner Sarlikiotis
Elisabeth Wolf-Heuss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sofotec GmbH
Original Assignee
Sofotec GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofotec GmbH filed Critical Sofotec GmbH
Publication of AU2001295483A1 publication Critical patent/AU2001295483A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
AU2001295483A 2000-09-01 2001-08-18 Solid peptide preparations for inhalation, and the production thereof Abandoned AU2001295483A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10043509A DE10043509A1 (en) 2000-09-01 2000-09-01 Solid peptide preparations for inhalation and their manufacture
DE10043509 2000-09-01
PCT/EP2001/009538 WO2002017882A1 (en) 2000-09-01 2001-08-18 Solid peptide preparations for inhalation, and the production thereof

Publications (1)

Publication Number Publication Date
AU2001295483A1 true AU2001295483A1 (en) 2002-03-13

Family

ID=7654908

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295483A Abandoned AU2001295483A1 (en) 2000-09-01 2001-08-18 Solid peptide preparations for inhalation, and the production thereof

Country Status (7)

Country Link
US (3) US20020122826A1 (en)
EP (1) EP1313452A1 (en)
AU (1) AU2001295483A1 (en)
CA (1) CA2356786A1 (en)
DE (1) DE10043509A1 (en)
TW (1) TWI296529B (en)
WO (1) WO2002017882A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2466525C (en) * 2001-12-07 2011-05-17 Eiffel Technologies Limited Synthesis of small particles
SI1699434T1 (en) 2003-09-02 2011-06-30 Norton Healthcare Ltd Process for preparing a medicament
WO2005077339A1 (en) * 2004-02-10 2005-08-25 E.I. Dupont De Nemours And Company Process for preparing stable sol of pharmaceutical ingredients and hydrofluorocarbon comprising milling the said sol, then transfert it into a canister
AU2005259523B2 (en) 2004-07-02 2011-06-09 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant
DE102006017320A1 (en) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant
EP1964564A1 (en) * 2007-04-19 2008-09-03 LAB International SRL Breakthrough Pain Management
FR2925066B1 (en) * 2007-12-18 2014-12-19 Bertin Technologies Sa DEVICE FOR MILLING A BIOLOGICAL SAMPLE
AU2009240586A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
DE102008037025C5 (en) * 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Process for the preparation of crystalline drug microparticles or a solid state drug particle form
DK3453400T3 (en) 2011-12-13 2021-04-06 Pieris Pharmaceuticals Gmbh PROCEDURES FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING BINDING OF IL-4 AND / OR IL-13 TO THEIR RESPECTORS
GB201307659D0 (en) * 2013-04-26 2013-06-12 Korea Coast Guard Commissioner Preparation of drug particles by micronisation
US20140377356A1 (en) * 2013-06-19 2014-12-25 Professional Compounding Centers Of America (Pcca) Inhalation Composition for Treating Respiratory Tract Infections
MX2017004765A (en) 2014-10-16 2017-07-27 Teva Branded Pharmaceutical Products R&D Inc Inhalable formulation.
AU2015338717B2 (en) 2014-10-31 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Powder formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629985A (en) * 1962-11-29
CA1155110A (en) * 1980-11-06 1983-10-11 Ronald E. Murray Recovery of a proteinaceous oat fraction from a dispersion thereof in hydrocarbon solvent
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
US5711934A (en) * 1994-04-11 1998-01-27 Abbott Laboratories Process for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants
DE4440337A1 (en) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmaceutical nanosuspensions for drug application as systems with increased saturation solubility and dissolution rate
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6444223B1 (en) * 1999-05-28 2002-09-03 Alkermes Controlled Therapeutics, Inc. Method of producing submicron particles of a labile agent and use thereof

Also Published As

Publication number Publication date
EP1313452A1 (en) 2003-05-28
TWI296529B (en) 2008-05-11
CA2356786A1 (en) 2002-03-01
US20020122826A1 (en) 2002-09-05
DE10043509A1 (en) 2002-03-14
US20090142407A1 (en) 2009-06-04
WO2002017882A1 (en) 2002-03-07
US20050014677A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
AU2001294192A1 (en) Solid preparations
AU2002223028A1 (en) Inhaler
AU2002232469A1 (en) Paired promotion architecture
AU2001236005A1 (en) Preparations stabilized over long time
AU2002218503A1 (en) Powdery preparations and methods for producing the same
AU2001264789A1 (en) Protein powder for pulmonary delivery
AU2001295483A1 (en) Solid peptide preparations for inhalation, and the production thereof
AU2001268750A1 (en) Flushed-seal respirator
AU2001276511A1 (en) Respirators
AU2002213452A1 (en) Applicator, e.g. for shaving preparations and the like
AU2001259450A1 (en) Cytoskeleton-associated proteins
AU2000277350A1 (en) Labeled peptides, and processes and intermediates useful for their preparation
AU2001288102A1 (en) Solid preparations
AU5150499A (en) Rationally designed peptides, production and use thereof
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU2002220924A1 (en) Antibodies, peptides, analogs and uses thereof
AU2001282521A1 (en) OCT preparations
AU2001272427A1 (en) Solid preparations
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2001252046A1 (en) New bacteriocin, production and use thereof
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU2001244863A1 (en) Apoptin-associating protein
AU2001280464A1 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof